» Articles » PMID: 38928128

A Systematic Review of Genetics- and Molecular-Pathway-Based Machine Learning Models for Neurological Disorder Diagnosis

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Jun 27
PMID 38928128
Authors
Affiliations
Soon will be listed here.
Abstract

The process of identification and management of neurological disorder conditions faces challenges, prompting the investigation of novel methods in order to improve diagnostic accuracy. In this study, we conducted a systematic literature review to identify the significance of genetics- and molecular-pathway-based machine learning (ML) models in treating neurological disorder conditions. According to the study's objectives, search strategies were developed to extract the research studies using digital libraries. We followed rigorous study selection criteria. A total of 24 studies met the inclusion criteria and were included in the review. We classified the studies based on neurological disorders. The included studies highlighted multiple methodologies and exceptional results in treating neurological disorders. The study findings underscore the potential of the existing models, presenting personalized interventions based on the individual's conditions. The findings offer better-performing approaches that handle genetics and molecular data to generate effective outcomes. Moreover, we discuss the future research directions and challenges, emphasizing the demand for generalizing existing models in real-world clinical settings. This study contributes to advancing knowledge in the field of diagnosis and management of neurological disorders.

Citing Articles

Special Issue "Machine Learning and Bioinformatics in Human Health and Disease"-Chances and Challenges.

Leiherer A Int J Mol Sci. 2024; 25(23).

PMID: 39684521 PMC: 11641040. DOI: 10.3390/ijms252312811.

References
1.
Gaiteri C, Ding Y, French B, Tseng G, Sibille E . Beyond modules and hubs: the potential of gene coexpression networks for investigating molecular mechanisms of complex brain disorders. Genes Brain Behav. 2013; 13(1):13-24. PMC: 3896950. DOI: 10.1111/gbb.12106. View

2.
Patel U, Anwar A, Saleem S, Malik P, Rasul B, Patel K . Artificial intelligence as an emerging technology in the current care of neurological disorders. J Neurol. 2019; 268(5):1623-1642. DOI: 10.1007/s00415-019-09518-3. View

3.
Chenausky K, Tager-Flusberg H . The importance of deep speech phenotyping for neurodevelopmental and genetic disorders: a conceptual review. J Neurodev Disord. 2022; 14(1):36. PMC: 9188130. DOI: 10.1186/s11689-022-09443-z. View

4.
Vatansever S, Schlessinger A, Wacker D, Umit Kaniskan H, Jin J, Zhou M . Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions. Med Res Rev. 2020; 41(3):1427-1473. PMC: 8043990. DOI: 10.1002/med.21764. View

5.
Kautzky A, Vanicek T, Philippe C, Kranz G, Wadsak W, Mitterhauser M . Machine learning classification of ADHD and HC by multimodal serotonergic data. Transl Psychiatry. 2020; 10(1):104. PMC: 7138849. DOI: 10.1038/s41398-020-0781-2. View